# FDA 483 - ABO Plasma Glassboro LLC - March 14, 2023

Source: https://www.keypedia.com/records/483/abo-plasma-glassboro-llc/950fad97-070d-4c31-9755-5adfb68ef661

> FDA 483 for ABO Plasma Glassboro LLC on March 14, 2023. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: ABO Plasma Glassboro LLC
- Inspection Date: 2023-03-14
- Product Type: biologics
- Office Name: New Jersey District Office
- Summary: An FDA inspection of ABO Plasma Glassboro LLC, a plasmapheresis center, revealed a significant failure in donor notification procedures. The firm did not make reasonable attempts to notify deferred donors within the required 8-week period, specifically for HCV reactive donors. This indicates a serious lapse in donor safety and regulatory compliance.

## Related Officers

- [Kish Bolden](https://www.keypedia.com/people/kish-bolden/e24957d4-927f-40c7-a7ca-860fedce2e3f)
- [issuing_officer](https://www.keypedia.com/people/emily-a-walters/e80b3581-ffba-4244-9030-b6c9496da932)

Company: https://www.keypedia.com/companies/abo-plasma-glassboro-llc/7ec78cd1-039a-4f32-a3a0-de4689398977

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248